| year | 2025Latest | 2024 | 2023 |
|---|---|---|---|
Revenue | 0 € | 0 € | 0 € |
Profit | - | - | - |
Assets | 21,3k € -18.2% | 26k € -53.0% | 55,4k € +30.7% |
Liabilities | 0 € | 0 € -100.0% | 30 € |
Equity | 21,3k € -18.2% | 26k € -53.0% | 55,3k € +30.6% |
Employees | 0 | 0 | 0 |
Overall rating | B+75/100 |
Financial health | 70/100 |
Credit history | 70/100 |
Legal history | 100/100 |
Business activity | 60/100 |
| Overall risk | Low |
No risk flags | |
Possible tax debts | |
No financial data available | |
Regular report filing | |
| Name, surname | Birth date | Position | Representation rights | Registered | |
|---|---|---|---|---|---|
| - | Independently | ||||
| - | Independently |
"Neiroloģisko slimību izpētes fonds" is located at Rīga, Brīvības gatve 410, LV-1024.
No, "Neiroloģisko slimību izpētes fonds" does not have an active VAT number and is not registered as a VAT payer.
"Neiroloģisko slimību izpētes fonds" was founded on January 23, 2018. The company has been operating for 8 years.
| Indicator | Value | Rank | Comparison | |
|---|---|---|---|---|
Company age | 8 years | - | 0% | |
Equity | 21 301,00 € | - | 0% | |
Assets | 21 301,00 € | - | 0% |
Annual financial report for 2025.
Annual financial report for 2024.
Annual financial report for 2023.
Annual financial report for 2022.
Annual financial report for 2021.
Annual financial report for 2020.
Registered in the Latvian company register.